1 |
Individual Descriptive Data for Participants (Halpern et al., 2012) ...
|
|
|
|
BASE
|
|
Show details
|
|
2 |
Individual Descriptive Data for Participants (Halpern et al., 2012) ...
|
|
|
|
BASE
|
|
Show details
|
|
3 |
The effects of intensive speech treatment on intelligibility in Parkinson’s disease: a randomised controlled trial
|
|
|
|
BASE
|
|
Show details
|
|
4 |
Crowdsourced ratings of dysarthria treatment (Nightingale et al., 2020) ...
|
|
|
|
BASE
|
|
Show details
|
|
5 |
Crowdsourced ratings of dysarthria treatment (Nightingale et al., 2020) ...
|
|
|
|
BASE
|
|
Show details
|
|
6 |
The effects of intensive speech treatment on intelligibility in Parkinson’s disease: a randomised controlled trial ...
|
|
|
|
BASE
|
|
Show details
|
|
7 |
The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial
|
|
|
|
In: EClinicalMedicine (2020)
|
|
BASE
|
|
Show details
|
|
8 |
Using Crowdsourced Listeners' Ratings to Measure Speech Changes in Hypokinetic Dysarthria: A Proof-of-Concept Study
|
|
|
|
In: Am J Speech Lang Pathol (2020)
|
|
BASE
|
|
Show details
|
|
9 |
Vowel Intelligibility in Children With and Without Dysarthria: An Exploratory Study
|
|
|
|
BASE
|
|
Show details
|
|
10 |
Evidence-based treatment of voice and speech disorders in Parkinson disease
|
|
|
|
In: Communicative Disorders Faculty Publications (2015)
|
|
Abstract:
Purpose of review Voice and speech impairments are present in nearly 90% of people with Parkinson disease and negatively impact communication and quality of life. This review addresses the efficacy of Lee Silverman Voice Treatment (LSVT) LOUD to improve vocal loudness (as measured by vocal sound pressure level vocSPL) and functional communication in people with Parkinson disease. The underlying physiologic mechanisms of Parkinson disease associated with voice and speech changes and the strength of the current treatment evidence are discussed with recommendations for best clinical practice. Recent findings Two randomized control trials demonstrated that participants who received LSVT LOUD were significantly better on the primary outcome variable of improved vocSPL posttreatment than alternative and no treatment groups. Treatment effects were maintained for up to 2 years. In addition, improvements have been demonstrated in associated outcome variables, including speech rate, monotone, voice quality, speech intelligibility, vocal fold adduction, swallowing, facial expression and neural activation. Advances in technology-supported treatment delivery are enhancing treatment accessibility. Summary Data support the efficacy of LSVT LOUD to increase vocal loudness and functional communication in people with Parkinson disease. Timely intervention is essential for maximizing quality of life for people with Parkinson disease.
|
|
Keyword:
LSVT LOUD; neuroplasticity; Parkinson disease; treatment
|
|
URL: https://digitalcommons.uri.edu/cmd_facpubs/45 https://doi.org/10.1097/MOO.0000000000000151
|
|
BASE
|
|
Hide details
|
|
11 |
Robust fundamental frequency estimation in sustained vowels: Detailed algorithmic comparisons and information fusion with adaptive Kalman filtering
|
|
|
|
BASE
|
|
Show details
|
|
12 |
The Effects of Two Speech Interventions on Speech Function in Pediatric Dysarthria
|
|
|
|
BASE
|
|
Show details
|
|
13 |
The Effects of Two Speech Interventions on Speech Function in Pediatric Dysarthria ...
|
|
|
|
BASE
|
|
Show details
|
|
15 |
Intensive treatment of dysarthria secondary to stroke
|
|
|
|
In: Communicative Disorders Faculty Publications (2012)
|
|
BASE
|
|
Show details
|
|
19 |
Intensive Voice Treatment (LSVT® LOUD) for dysarthria secondary to stroke
|
|
|
|
In: Communicative Disorders Faculty Publications (2009)
|
|
BASE
|
|
Show details
|
|
|
|